Johnson & Johnson (JNJ) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - General industry. The company is headquartered in New Brunswick, NJ, United States. The current CEO is Joaquin Duato.
JNJ has IPO date of 1943-01-02, 138,100 full-time employees, listed on the NYSE, a market capitalization of $578.62B.
Johnson & Johnson is a global healthcare company focused on innovative pharmaceuticals and medical devices following its 2023 strategic separation of its consumer health business into Kenvue Inc. The company's Innovative Medicine segment develops prescription medications for complex diseases including rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders. Its MedTech segment provides advanced medical technology solutions spanning electrophysiology, neurovascular care, orthopedic implants, surgical systems, and ACUVUE contact lenses. Operating worldwide and headquartered in New Brunswick, New Jersey, Johnson & Johnson serves hospitals, healthcare professionals, wholesalers, and retailers while maintaining its mission of advancing human health since 1886.
